Photo extracted from cbdschool.com
Dangerous Drug Board (DDB) Approved in Principle the use of CBC for Epilepsy in the Philippines last December, 2019.
I was watching the evening news report on TV and somewhat bored and sleepy looking at the newscaster. The next report made me fully awake of what I’ve heard: The use of Cannabidiol (CBD) in the Philippines is now approved! Now, this is somewhat an exciting news! It said that the Dangerous Drug Board (DDB) has ‘approved in principle’ as to the use of cannabis for epilepsy. Now they’re making sense.
Undersecretary Benjie Reyes, a permanent DDB member said that the World Health Organization (WHO) made the recommendation to grant the use of CBD with additional 0.1%THC. It’s one step forward for the legalization of marijuana in the Philippines. The advocates who were responsible for pushing the use of medical marijuana to be legalized in the Philippines scored a triumphant victory.
CBD has long been legalized in several states but not in the Philippines. In fact, one mother with a Down syndrome child was stopped at the airport, for questioning since she carried along with them some cannabis drugs which was intended for her sick child.
In 2018, the US Drug Enforcement Agency has approved the use of CBC with 0.1% THC. The Philippines is one of the signatories during the UN Convention on Psychotropic drugs. On same year, the use of Epidiolex was approved by the FDA.
EPIDIOLEX was manufactured by GW Pharmaceuticals. This CBD oral solution is intended to treat seizures related with syndromes such as Lennox-Gastaut and Dravet, specifically for patients aged 2 yrs old and above. The use of such will alleviate seizures of these kind of patients. So far, this is the first of its kind with purified substance from cannabis and the first FDA approved for treatment of patients suffering from Dravet syndrome.
According to Scott Gottlieb, a doctor and FDA commissioner, that this approval is a significant indication that ingredients containing marijuana when properly evaluated could be beneficial towards relevant medical therapies.
As of 2014, about 250,000 children suffered from epileptic seizure disorder, Dr. Donnabel Cunanan said, PCCS spokesperson and House Bill no. 279 lead advocate. She said that if the bill passed is approved and becomes a law, it will benefit a lot in treating patients with chronic medical condition.
Just in case, Medical Cannabis Compassionate Centers (MCCC) will be established and authorized to supply, sell and allocate medical cannabis to the right beneficiaries via S2-licensed pharmacists. It will be reclassified to Schedule 4, re: accepted for medical use (with low potential for abuse) in the Philippines. Further, the University of the Philippines College of Medicines will be the only one authorized to import the said medicine and have the needy patients registered in order to avail of Epidiolex for free. The reason behind is that a year’s supply for one patient would cost them about $32,500. Now that’s something!
With all of the above, propagation of marijuana for any purpose is still a big NO-NO under Republic Act – 9165. Meanwhile, only those with S2 licensed specialist physicians will be authorized to prescribe these medicines using special “yellow” pads, to procure and avail of drugs that are registered outside the Philippines. This is a good sign that legalization of medical marijuana is slowly encroaching the approval of the Senate not only for epilepsy, but for other kinds of health deficiency sooner or later.